Improving vaccines for tuberculosis
ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)
['FUNDING_OTHER'] · UNIVERSITY OF SYDNEY · NIH-11167404
This study is looking to create better vaccines for tuberculosis, especially for people at higher risk like those with HIV, by testing different ingredients that help boost the vaccine's effectiveness in animals to find the best options for future vaccines.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SYDNEY (nih funded) |
| Locations | 1 site (SYDNEY, AUSTRALIA) |
| Trial ID | NIH-11167404 on ClinicalTrials.gov |
What this research studies
This research focuses on developing better vaccines for tuberculosis (TB), particularly for individuals at higher risk, such as those living with HIV. The team will compare different vaccine adjuvants, which are substances that enhance the body's immune response to the vaccine, alongside specific TB antigens. By using mouse models and non-human primates, they aim to identify the most effective combinations that could lead to new TB vaccines. The ultimate goal is to create vaccines that can prevent TB infection and improve treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for tuberculosis, including those living with HIV.
Not a fit: Patients who are not at risk for tuberculosis or those who have already been vaccinated may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that significantly reduce the incidence of tuberculosis, especially in vulnerable populations.
How similar studies have performed: Previous research has shown promise in developing effective vaccine adjuvants for other diseases, suggesting potential success for this approach in tuberculosis.
Where this research is happening
SYDNEY, AUSTRALIA
- UNIVERSITY OF SYDNEY — SYDNEY, AUSTRALIA (ACTIVE)
Researchers
- Principal investigator: BRITTON, WARWICK — UNIVERSITY OF SYDNEY
- Study coordinator: BRITTON, WARWICK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Disease, Disorder